Immuneering Corporation
Immuneering Corporation（IMRX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
imrx · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
+205.3% upside
Low
$12.00
Median: $12 · Last Close: $3.93
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.73 | ↓ 5.00% |
1-day model range: $3.69–$3.77. Peak: $3.77 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMRX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-09 | Needham | Maintains | Buy→Buy |
| 2025-11-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-09-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-26 | Chardan Capital | Maintains | Buy→Buy |
| 2025-09-25 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-09-15 | Needham | Maintains | Buy→Buy |
| 2025-08-26 | Needham | Maintains | Buy→Buy |
| 2025-08-14 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-18 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Immuneering Corporation (IMRX) stock. Of the recent 57 rating actions, 2 were upgrades and 4 were downgrades. 11 analysts currently cover IMRX.
分析师推荐趋势
IMRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$21M
↓ 58.9% YoY
Revenue Next Year
$16M
↓ 24.8% YoY
EPS This Year
$-1.14
EPS Next Year
$-1.34
↑ 17.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMRX EPS of $-1.14 for the current fiscal year, based on estimates from 5 analysts. The IMRX revenue forecast is $21M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMRX 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IMRX 的共识目标价为 $12.00（+205.3% 上行空间），分析师共识为 Buy。
IMRX 的短期预测（明日）为 $3.73（-5.00%）。
Immuneering Corporation 在 NASDAQ 上市，代码 IMRX。IMRX 在 2027 年的整体展望偏积极，在覆盖分析师中约 64% 对应 Buy 共识。
常见问题
IMRX 预测 · 8 个问题根据 11 位华尔街分析师，IMRX 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $3.93，隐含约 +205.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.